ArticleA startup aims to edit human embryos — sparking ethical and regulatory alarms
A new biotech startup is pursuing gene-editing of human embryos to prevent inherited diseases. While the founders emphasise a therapeutic focus, the move reopens a fraught debate about heritable genome editing’s safety, ethics and future.
